Page last updated: 2024-08-26

norcantharidin and Leukemia L 1210

norcantharidin has been researched along with Leukemia L 1210 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Au-Yeung, SC; Han, X; Ho, YP; Lin, G; To, KK; Wang, X1

Other Studies

1 other study(ies) available for norcantharidin and Leukemia L 1210

ArticleYear
Potential new antitumor agents from an innovative combination of demethylcantharidin, a modified traditional Chinese medicine, with a platinum moiety.
    Journal of medicinal chemistry, 2001, Jun-21, Volume: 44, Issue:13

    Topics: Animals; Antineoplastic Agents, Phytogenic; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Non-Small-Cell Lung; Cell Division; DNA, Neoplasm; Enzyme Inhibitors; Humans; Leukemia L1210; Liver Neoplasms, Experimental; Lung Neoplasms; Medicine, Chinese Traditional; Mice; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Phosphoprotein Phosphatases; Phytotherapy; Plants, Medicinal; Tumor Cells, Cultured

2001